时间：2025-01-13 10:20:47 来源：Nhà cái uy tín 作者：Cúp C2 阅读：301次

Parliament approves amendments to pharmacy law

November 21,soi kèo nhận định 2024 - 18:42 Your browser does not support the audio element. On drug price management, the NA Standing Committee reviewed and concurred with the Government’s proposal to implement measures for publishing projected wholesale prices for prescription drugs.

Legislators on Thursday voted to pass the Law on amendments and supplements to a number of articles of the Law on Pharmacy at the ongoing plenary parliamentary session in Hà Nội. — VNA/VNS Photo

HÀ NỘI — The National Assembly (NA) on November 21 approved the Law on amendments and supplements to a number of articles of the Law on Pharmacy, with 426 deputies present at the session voting in favour, accounting for 88.94 per cent of the total number of NA deputies.

Among the amendments, the revised law introduces changes to Article 56 of the current law concerning the authority, documentation, procedures, and timelines for issuing, renewing, amending, or supplementing licenses for drug registration and raw materials serving drug production. Specifically, the validity period for drug registration licenses is set at five years from the date of issuance or renewal, except in certain cases. For drugs requiring ongoing safety and efficacy monitoring, the validity period is three years.

Earlier, Nguyễn Thùy Anh, Chairwoman of the NA Committee for Social Affairs, presented a report on the draft of the freshly adopted law.

She stated that in response to feedback from deputies, the NA Standing Committee directed the inclusion of provisions to control the number of registration licenses for drugs with identical active ingredients and raw materials, aligning with socioeconomic conditions over time as well as to prioritise investment in IT infrastructure and digital transformation in pharmaceutical activities.

Regarding preferential policies and investment support in the pharmaceutical industry, based on the majority opinion of deputies, the NA Standing Committee agreed with the Government’s proposal to apply special investment incentives for new projects in the pharmaceutical field with a total investment capital of at least VNĐ3 trillion (US$118.02 million). These projects must disburse a minimum of VNĐ1 trillion within three years from the date of investment registration certificate issuance or investment policy approval.

On drug price management, the NA Standing Committee reviewed and concurred with the Government’s proposal to implement measures for publishing projected wholesale prices for prescription drugs. — VNS

(责任编辑：Thể thao)

上一篇：Tạm đình chỉ công tác trưởng công an xã đánh người dân ở Bình Phước
下一篇：Vietlott tăng trưởng vượt bậc năm 2024, sẻ chia nhiều cơ hội tốt hơn đến cộng đồng

• 
• 
• 
• 
• 
• 
• 
•